Clinical Trials Directory

Trials / Unknown

UnknownNCT03998631

Comparison of Carbon Dioxide and Saline Flush to Saline Flush in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia

Comparison of Carbon Dioxide Flush and Saline Flush to Saline Flush Alone in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Thoracic endovascular repair (TEVAR) and transcatheter aortic valve implantation (TAVI) are standard of care procedures to treat thoracic aortic aneurysm or severe aortic stenosis, respectively. Both procedures have a high risk of stroke and silent infarction. Gas has been detected in the cerebral vasculature during these procedures and associated with DWI positive lesions on MRI. The hypothesis is that air emboli contribute to stroke and silent infarction. The investigators propose addressing air emboli by flushing the device with carbon dioxide prior to flushing with saline. This is a pilot study comparing standard saline flush alone to carbon dioxide flushing with saline flush.

Conditions

Interventions

TypeNameDescription
PROCEDURECarbon Dioxide and Saline FlushThe TEVAR or TAVI device will be flushed with approximately 1.2L of medical grade carbon dioxide using a 60mL syringe and connecting tubing. The reservoir will then be flushed with at least 60mL of standard saline prior to deployment to minimize bubbles in the saline.
PROCEDUREStandard Saline FlushStandard of care flushing of the TEVAR or TAVI device with normal saline.

Timeline

Start date
2019-07-20
Primary completion
2020-12-31
Completion
2021-03-31
First posted
2019-06-26
Last updated
2020-09-23

Locations

1 site across 1 country: Canada

Regulatory

Source: ClinicalTrials.gov record NCT03998631. Inclusion in this directory is not an endorsement.